Latest News

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if you pick the right...

It's not a stretch to say that OT Logistics S.A.'s ( WSE:OTS ) price-to-sales (or "P/S") ratio of 0.6x right now seems...

Sify Technologies reported third-quarter 2025 results with sales rising to INR 11,596 million from INR 10,491 million a year earlier, while net loss widened to INR 329 million. Management underscored strong data center momentum, plans for an IPO of its Sify Infinit Spaces subsidiary, and ongoing expansion highlighted by a new Karnataka facility, signalling a business model heavily geared toward capital-intensive infrastructure for AI-era demand. We’ll now examine how the planned IPO of Sify...

Alaska Air Group (ALK) has wrapped up FY 2025 with Q4 revenue of US$3.6 billion and basic EPS of US$0.18, alongside net income of US$21 million. This sets a measured tone for its latest update. The company has seen revenue move from US$3.5 billion and EPS of US$0.56 in Q4 2024 to US$3.6 billion and EPS of US$0.18 in Q4 2025. Trailing twelve month revenue sits at US$14.2 billion with EPS of US$0.85 and a net margin that remains thin after a large one off loss in the last year, keeping the...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if you buy shares in a...

Redaptive previously announced the completion of the first phase of a multi-site energy modernization program with UniFirst, upgrading LED lighting across 39 U.S. facilities covering more than 2.5 million square feet and aiming to cut energy use and emissions over the coming decade. This program is projected to save UniFirst several million dollars in energy costs while avoiding over 21,000 metric tons of CO2 emissions, underscoring how operational efficiency and sustainability initiatives...

Tsogo Sun Limited's ( JSE:TSG ) price-to-earnings (or "P/E") ratio of 7.1x might make it look like a buy right now...

When close to half the companies in the United Kingdom have price-to-earnings ratios (or "P/E's") above 17x, you may...

Most readers would already be aware that Morgan Sindall Group's (LON:MGNS) stock increased significantly by 5.0% over...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

The Teneo AI AB (publ) ( STO:TENEO ) share price has fared very poorly over the last month, falling by a substantial...

With a median price-to-earnings (or "P/E") ratio of close to 17x in the United Kingdom, you could be forgiven for...

There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...

B.P. Marsh & Partners PLC ( LON:BPM ) will increase its dividend on the 27th of February to £0.0698, which is 2.9...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

There wouldn't be many who think DocMorris AG's ( VTX:DOCM ) price-to-sales (or "P/S") ratio of 0.3x is worth a mention...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Over the past year, many ADvTECH Limited ( JSE:ADH ) insiders sold a significant stake in the company which may have...

With a price-to-earnings (or "P/E") ratio of 6.2x Stalexport Autostrady S.A. ( WSE:STX ) may be sending very bullish...

KWS SAAT SE KGaA's (ETR:KWS) stock is up by a considerable 9.8% over the past month. Since the market usually pay for a...

Columbia Banking System (COLB) has wrapped up FY 2025 with fourth quarter revenue of US$694 million and basic EPS of US$0.73, alongside trailing twelve month revenue of about US$2.2 billion and EPS of US$2.31. These results put fresh numbers on the table for investors watching its profitability story. Over recent periods, the company has seen revenue move from US$458.9 million in Q4 2024 to US$694 million in Q4 2025, while EPS shifted from US$0.69 to US$0.73. This sets the backdrop for how...

GSK has signed a definitive agreement to acquire RAPT Therapeutics (NasdaqGM:RAPT). The deal centers on ozureprubart, a long acting anti-IgE antibody in Phase IIb trials for food allergy prophylaxis. The transaction brings a food allergy candidate into GSK’s immunology and inflammation portfolio. RAPT Therapeutics, trading at $57.63, has recently seen very large 1 year returns and strong short term moves, with the share price up 64.2% over the past week and 60.8% over the past month. Year...